Holly Leslie reflects on the origin of this year’s Nobel prize-winning, CRISPR-Cas9 technology, and explores how scientists are beginning to use gene editing approaches on their quest for new medical treatments in hereditary disease.
The Royal Astronomical Society made a striking announcement in September which led to a lot of speculation. Deep Bandivadekar discusses what it really meant and the way forward.
Liam Rooney and Rebecca McHugh discuss the lesser known side of microbial co-operation and competition and how we can exploit this for our own benefit.
Bringing the fight to antibiotic resistance with the next generation of antibacterial weapons.